The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
Catherine Liloia
Advertisement
Catherine Liloia, [email protected], is director at PPD Laboratories’ GMP cell lab.
Articles by Catherine Liloia
Advertisement
Latest Updated Articles
Advertisement
Advertisement